Increased peripheral mononuclear cells expression of adhesion molecules in alcoholic cirrhosis: Its relation to immune activation

Journal of Hepatology

Volumn 27, Issue 3, 1997, Pages 477-483

  Luna Casado, Luis ^a   Diez Ruiz, Antonio ^a   Gutierrez Gea, Francisco ^a   Santos Perez, Juan Luis ^a   Rico Irles, Jose ^a   Wachter, Helmut ^b   Fuchs, Dietmar ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Adhesion; Alcoholic cirrhosis; Cell surface markers; Cytokines; Immune activation; Intercellular adhesion molecule (ICAM); Lymphocyte functional antigen (LFA); Neopterin

Indexed keywords

CELL SURFACE MARKER; CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CELL ADHESION; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE SUBPOPULATION; MACROPHAGE ACTIVATION; MALE; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0030821521     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80351-0     Document Type: Article

References (25)

1. Giron JA, Alvarez-Mon M, Menendez-Caro JL, Abreu L, Abillos A, Manzano L, et al. Increased spontaneous and lymphokine- conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients. Hepatology. 16:1992;664-670.
2. Deviere J, Denys C, Schandene L, Romasco F, Adlee M, Wybran J, et al. Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis. Clin Exp Immunol. 72:1988;377-382.
3. Diez-Ruiz A, Santos-Perez JL, Lopez-Martinez G, Gonzalez-Calvin J, Gil-Extremera B, Gutierrez-Gea F. Tumor necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis. Alcohol Alcohol. 28:1993;319-323.
4. Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, et al. Cell-mediated injury in alcoholic liver disease. Gastroenterology. 105:1993;254-266.
5. Makgoba MW, Sanders ME, Shaw S. The CD-2-LFA-3 and LFA 1-ICAM pathways: relevance to T-cell recognition. Immunol Today. 10:1989;417-422.
6. Tanaka Y, Kobayashi K, Takahashi A, Arai I, Higuchi I, Otomo S, et al. Inhibition of inflammatory liver injury by a monoclonal antibody aginst lymphocyte function-associated antigen-1. J Immunol. 151:1993;5088-5095.
7. Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E, et al. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology. 16:1992;810-814.
8. Alcoholic liver disease: morphological manifestations. Lancet. 1:1981;707-711.
9. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagous for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
10. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today. 13:1992;93-99.
11. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 137:1986;245-254.
12. Burra P, Hubscher SG, Shaw J, Elias E, Adams DH. Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut. 33:1992;268-271.
13. Garcia-Barcina M, Lukomska B, Gawron W, Winnock M, Viral-Vanaccocha F, Bioulac-Sage P, et al. Expression of cell adhesion molecules on liver-associated lymphocytes and their ligands on sinusoidal lining cells in patients with benign or malignant disease. Am J Pathol. 146:1995;12406-12413.
14. Volpes R, van der Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology. 12:1990;59-65.
15. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlen R, et al. Increased expression of ICAM-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 14:1991;426-432.
16. Adams DH, Burra P, Hubscher SG, Elias E, Newman W. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology. 19:1994;588-594.
17. Stauton DE, Dustin ML, Erickson HP, Springer TA. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell. 61:1990;243-254.
18. Rothlein R, Mainolfi E, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol. 147:1991;3788-3793.
19. Thomson AW, Satoh S, Nüssler AK, Tamura K, Woo J, Gavaler J, et al. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol. 95:1994;83-90.
20. Morita M, Watanabe Y, Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology. 19:1994;426-431.
21. Volpes R, van der Oord JJ, Desmet VJ. Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation. Hepatology. 13:1991;826-829.
22. Kvale D, Brandtzaeg P. Immune modulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human hepatocytic cell lines. J Hepatol. 17:1993;347-352.
23. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, et al. Neopterin and soluble tumor necrosis factor receptor type I in alcoholic cirrhosis. Hepatology. 21:1995;976-978.
24. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as marker for activated cell-mediated immunity: application in HIV infection. Immunol Today. 9:1988;150-155.
25. Diez-Ruiz A, Kaiser G, Jäger H, Birkmann J, Tilz GP, Wachter H, et al. Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation. Int Arch Allergy Immunol. 102:1993;56-60.